[en] Tilted peptides are short sequence fragments (10-20 residues long) that possess
an asymmetric hydrophobicity gradient along their sequence when they are helical.
Due to this gradient, they adopt a tilted orientation towards a single
lipid/water interface and destabilize the lipids. We have detected those peptides
in many different proteins with various functions. While being all
tilted-oriented at a single lipid/water interface, no consensus sequence can be
evidenced. In order to better understand the relationships between their
lipid-destabilizing activity and their properties, we used IMPALA to classify the
tilted peptides. This method allows the study of interactions between a peptide
and a modeled lipid bilayer using simple restraint functions designed to mimic
some of the membrane properties. We predict that tilted peptides have access to a
wide conformational space in membranes, in contrast to transmembrane and
amphipathic helices. In agreement with previous studies, we suggest that those
metastable configurations could lead to the perturbation of the acyl chains
organization and could be a general mechanism for lipid destabilization. Our
results further suggest that tilted peptides fall into two classes: those from
proteins acting on membrane behave differently than destabilizing fragments from
interfacial proteins. While the former have equal access to the two layers of the
membrane, the latter are confined within a single lipid layer. This could be in
relation with the organization of lipid substrate on which the peptides
physiologically act.
Brasseur R. (1991) Differentiation of lipid-associating helices by use of 3-dimensional molecular hydrophobicity potential calculations. J Biol Chem 266:16120-16127.
Brasseur R., Pillot T., Lins L., Vandekerckhove J., Rosseneu M. (1997) Peptides in membranes: Tipping the balance of membrane stability. TiBS 22:167-171.
Brasseur R. (2000) Tilted peptides: A motif for membrane destabilization (hypothesis). Mol. Membr Biol 17:31-40.
Horth M., Lambrecht B., Chuah Lay Khim M., Bex F., Clothilde C., Ruysschaert J.M., Burny A., Brasseur R. (1991) Theoretical and functional analysis of the SIV fusion peptide. EMBO J 10:2747-2755.
Vonèche V., Portetelle D., Kettmann R., Willems L., Limbach K., Paoletti E., Ruysschaert J.M., Burny A., Brasseur R. (1992) Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion via oblique insertion in the lipid bilayer or their target cells. Proc Natl Acad Sci 89:3810-3814.
Martin I., Defrise-Quertain F., Mandieau V., Nielsen N.M., Saermark T., Burny A., Brasseur R., Ruysschaert J.M., Vandenbranden M. (1991) Fusogenic activity of SIV (simian immunodeficiency virus) peptides located in the GP32 NH2 terminal domain. Biochem Biophys Res Commun 175:872-879.
Martin I., Dubois M.C., Defrise-Quertain F., Saermark T., Burny A., Brasseur R., Ruysschaert J.M. (1994) Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of the SIV GP32 and their mode of insertion into the lipid bilayer: An infrared spectroscopy study. J Virol 68:1139-1148.
Lambert G., Decout A., Vanloo B., Rouy D., Duverger N., Kalopissis A., Vanderkerckhove J., Chambaz J., Brasseur R., Rosseneu M. (1998) The C-terminal helix of human apo AII promotes the fusion of unilamellar liposomes and displaces apo A-I from high-density lipoproteins. Eur J Biochem 253:328-338.
Pérez-Méndez O., Vanloo B., Goethals M., Peelman F., Vandekerckhove J., Brasseur R., Rosseneu M. (1998) Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids. Eur J Biochem 256:570-579.
Talmud P., Lins L., Brasseur R. (1996) Prediction of signal peptide functional properties: A study of the orientation and angle of insertion of yeast invertase mutants and human apolipoprotein B signal peptide variants. Prot Eng 9:317-321.
Rahman M., Lins L., Thomas-Soumarmon A., Brasseur R. (1997) Are amphipathic asymmetric peptides ubiquitous structures for membrane destabilisation?. J Mol Model 3:203-215.
Pillot T., Goethals M., Vanloo B., Talussot C., Brasseur R., Vandekerckhove J., Rosseneu M.Y., Lins L. (1996) Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. J Biol Chem 271:28757-28765.
Pillot T., Lins L., Goethals M., Vanloo B., Baert J., Vandekerckhove J., Rosseneu M., Brasseur R. The 118-135 peptide of the human Prion protein promotes the fusion of unilamellar liposomes together with amyloid fibril formation. J Mol Biol 274:381-393.
McLaurin J., Chakrabartty A. (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implication for neurotoxicity. J Biol Chem 271:26482-26489.
Hedge R.S., Tremblay P., Groth D., DeArmond S.J., Prusiner S.B., Lingappa V.R. (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402:822-826.
Soto C., Frangione B. (1995) Two conformational states of amyloid beta-peptide: Implications for the pathogenesis of Alzheimer's disease. Neurosci Lett 186:115-118.
Prusiner S.B. Prion biology and diseases, Cold Spring Harbor, NY: Cold Spring Harbor Press; 1999.
Ducarme P., Rahman M., Brasseur R. (1998) IMPALA: A simple restraint field to simulate the biological membrane in molecular structure studies. Proteins 30:357-371.
Brasseur R., Lins L., Vanloo B., Ruysschaert J.M., Rosseneu M. (1992) Molecular modeling of the amphipathic helices of the plasma apolipoproteins. Proteins 13:246-257.
Brasseur R. (1990) TAMMO: Theoretical analysis of membrane molecular organisation., Molecular description of biological membrane components by computer-aided conformational analysis. Boca Raton, FL: CRC Press; 203-219.
Dugi K.A., Dichek H.L., Talley G.D., Brewer H.B. Jr., Santamarina-Fojo S. (1992) Human lipoprotein-lipase: The loop covering the catalytic site is essential for interaction with lipid substrates. J Biol Chem 267:25086-25091.
Wang S., Wang X., Deng L., Rassaet E., Milne R.W., Tall A.R. (1993) Point mutagenesis of carboxy-terminal amino acids of cholesteryl ester transfer protein. Opposit faces of an amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody. J Biol Chem 268:1955-1959.
Lund-Katz S., Anatharamaiah G.M., Venkatachalapathi Y.V., Segrest J.P., Phillips M.C. (1990) Nuclear magnetic resonance investigation of the interactions with phospholipids of an amphipathic α-helix-forming peptide of the apolipoprotein class. J Biol Chem 21:12217-12223.
Sparrow J.T., Ferenz C.R., Gotto A.M., Pownall H.J. (1981) The thermodynamics of lipid-protein association and the activation of LCAT by synthetic lipopeptides. Peptides. Proc 7th Am Peptide Symp. , Rich DH, Gross E, editors. Rockford, IL, Pierce Chemical Co.; 253-262.
Holvoet P., Zhao Z., Vanloo B., Vos R., Deridder E., Dhoest A., Taveirne J., Brouwers E., Demarsin E., Engelborghs Y. (1995) Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants. Biochemistry 34:13334-13342.
Sparrow J.T., Sparrow D.A., Fernando G., Culwell A.R., Kovar M., Gotto A.M.J. (1992) Apolipoprotein E: Phospholipid binding studies with synthetic peptides from the carboxyl terminus. Biochemistry 31:1065-1068.
Lins L., Thomas-Soumarmon A., Pillot T., Vandekerckhove J., Rosseneu M., Brasseur R. (1999) Molecular determinants of the interaction between the C-terminal domain of Alzheimer b-amyloid peptide and apolipoprotein E a-helices. J Neurochem 73:758-769.
Habermann E. (1972) Bee and wasp venoms. Science 177:314-322.
Morgan C.G., Williamson H., Fuller S., Hadson B. (1983) Melittin induces fusion of unilamellar phospholipid vesicles. Biochim Biophys Acta 732:668-674.
Naito A., Nagao T., Norisada T., Mizuno T., Tuzi S., Saito H. (2000) Conformation and dynamics of melittin bound to magentically oriented lipid bilayers by solid-state 31P and 13C NMR spectroscopy. Biophys J 78:2405-2417.
Lin J.H., Baumgaertner A. (2000) Stability of a melittin pore in a lipid bilayer: A molecular dynamics study. Biophys J 78:1714-1724.
Jonas A. (1987) Lecithin cholesterol acyltransferase., Gotto AM, editor. Plasma lipoproteins. New York: Elsevier Science; 299-335.
Jonas A. (1991) LCAT in the metabolism of high density lipoproteins. Biochim Biophys Acta 1084:205-220.
Durell S.R., Martin I., Ruysschaert J.M., Shai Y., Blumenthal R. (1997) What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion. Mol Membr Biol 14:97-112.
Eisenberg D., Weiss R., Terwilliger T. (1982) The helical hydrophobic moment: A measure of the amphiphilicity of the α-helix. Nature 299:371-374.
Beuve-Mery D., Rahman M., Ducarme P., Brasseur R. (2000) Practical aspects of computational chemistry calculations through PC networks: The RAMSES-Beowulf implementation. J Comput Chem 22:172-177.
Thomas A., Bouffioux O., Geeurickx D., Brasseur R. (2001) Pex, analytical tools for PDB files I. GF-Pex: Basic file to describe a protein. Proteins 43:28-36.
Creighton T. Chemical properties of polypeptides, 2nd ed. , New York: WA Freeman; 1993, 1-46.
